Tags Posts tagged with "DDAP"


Image by DarkmoonArt_de from Pixabay

Save the date for the Pennsylvania Department of Drug and Alcohol Program’s (DDAP) 2024 Recovery Month kickoff event “Share the Hope: A Recovery Story,” featuring guest speaker DDAP Secretary Latika Davis-Jones. The event will take place from 10:00 am – 12:00 pm on September 12 at Sailors and Soldiers Grove, Capitol Complex, 531 Commonwealth Ave., Harrisburg, PA. More details will be provided soon.

Pennsylvania has launched a new website for the Enterprise Licensing System (ELS) project, designed to streamline and modernize the licensing, permitting, registration, certification, and incident management systems across four state agencies: the Department of Human Services, the Department of Health, the Department of Aging, and the Department of Drug & Alcohol Programs. The ELS will be implemented in stages over the next two years, with the aim of improving interagency collaboration and operational efficiency.

For more information and to stay updated on the ELS project, subscribe to the ELS ListServ. If you need additional information or have questions, you can reach out to OCYF through the Contact Us form.

If you have any other questions, please contact RCPA COO and Policy Director Jim Sharp.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is hosting its annual Recovery Month Kick-Off event on September 12 at Soldiers and Sailors Grove in Harrisburg. The focus of the 2024 kick-off will be total wellness in recovery. To participate in the event, complete the survey by June 28 to indicate if you or your agency would like to provide an interactive activity (such as yoga, music therapy, or meditation) or have a resource table. Space is limited, so responses will be accepted on a first-come, first-served basis. The event will take place outdoors, with a rain date of Sept. 13. It will be held at the venue located on the fountain side of the state capitol building between Commonwealth Avenue and State Street.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has issued Licensing Alert 05-2024 to provide and organize guidance on the interpretation and implementation of regulatory licensing requirements for staff education, training, and supervision, as well as client-to-staff/counselor ratios for drug and alcohol treatment providers.

DDAP has issued individual licensing alerts over time that focus on specific regulation topics. This licensing alert organizes previous relevant active licensing alerts, as well as provide additional guidance for Chapter 704 staffing regulations.

Licensing Alert 05-2024 is available online.

Folders with the label Applications and Grants

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) announced the availability of $6.5 million in funding to expand drop-in center services for individuals with substance use disorders (SUD) across Pennsylvania.

Drop-in centers provide a safe, judgment-free place for people to receive daily essentials, engage with staff to learn about the possibility of recovery and treatment options, and, when ready, get connected to those services. They also provide harm reduction and recovery support services.

Eligible applicants, including existing community organizations, single county authorities, and DDAP-licensed treatment providers, can find the grant application online. Approximately eight grants of up to $750,000 will be awarded.

Some examples of services provided by drop-in centers include but are not limited to:

  • Harm-reduction for substance use by incorporating overdose prevention and legally permissible harm reduction efforts into existing services;
  • Addressing social determinants of health through the provision of daily essentials;
  • Access to care and case management systems;
  • Access to free healthcare including wound care, Hepatitis C/HIV testing, reproductive healthcare, and dental care;
  • Referrals to SUD level of care assessments, treatment, including medication for opioid use disorder, behavior health resources, case management services, benefits services, and legal services;
  • Survival resources such as shelter and warmth or cooling;
  • Public restrooms, shower, and laundry facilities;
  • Clothing and hygiene product distribution;
  • Mail services;
  • Professionally facilitated support groups which offer education, emotional and social support, practical help, and more; and
  • Advocacy and other supportive services required to navigate complex issues impacting special populations.

DDAP is placing a focus on health equity as a part of this grant opportunity. Applicants must include a description of their current engagement with diverse populations, including communities of color, LGBTQ+ individuals, persons with disabilities, and those residing in rural and urban settings, and provide detailed information about how the project will engage and provide access to these diverse populations.

All applications must be submitted electronically by 12:00 pm on Friday, April 12, 2024. Applications will be competitively reviewed and scored based upon the applicant’s adherence to the funding announcement guidelines and a timely submission to DDAP.

Funding for these grants is provided from the opioid settlement funding that was appropriated to DDAP by the General Assembly for the 2023/24 fiscal year.

Questions regarding the grants and the application process should be forwarded via email.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is conducting a survey on regulatory reform that will help guide its work in this area. The survey is available online, and responses are due by close of business March 28, 2024. Regulations governing licensed addiction treatment providers under DDAP’s authority can be found in the Pennsylvania Code and Bulletin. If you have any questions, please contact Cynthia Beidler.

With state and federal laws governing the use and disclosure of confidential substance use disorder (SUD) information having undergone significant changes, including the recently announced final rule modifying 42 CFR Part 2, the Pennsylvania Department of Drug and Alcohol Programs (DDAP) issued Licensing Alert 04-2024 to clarify the identification of recipients of confidential SUD information for treatment, payment, or healthcare operations for compliance with 28 Pa. Code § 709.28(c)(1).

Consent forms must now include names of recipients, with a single form applicable for future disclosures, using a generalized recipient description. Treatment providers are urged to ensure their consent forms comply with these regulations and updated policies. For additional questions treatment providers can contact the Bureau of Program Licensure.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) released the Phase 1 findings of its statewide stakeholder engagement tour, detailing actions to enhance community and treatment provider engagement and improve access to substance use disorder services. The findings address various challenges within the behavioral health workforce, regulatory and data aspects of service delivery, and unmet needs within priority populations. For more details, read the full press release.

The Department of Drug and Alcohol Programs (DDAP) is hosting its monthly ASAM technical assistance webinar at 10:00 am on Monday, March 4. The topic is “Individualizing Services and Group Development” and will include a discussion on documentation with ASAM’s Golden Thread, transitioning to clinically driven treatment, and strategies for group development. You can email DDAP’s ASAM Transition team to learn more. ASAM technical assistance webinars are held every first Monday of the month at 10:00 am via Microsoft Teams.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has issued Information Bulletin 01-2024, reminding single county authorities (SCA) and residential treatment providers about obligations regarding individuals on high doses of medication for opioid use disorder (MOUD). It emphasizes adherence to Part 4.04 of the Case Management and Clinical Services Manual and relevant licensure standards. It states that SCAs must ensure providers do not exclude individuals using MOUD and that treatment is individualized without restrictions. Providers may lose funds for restricting admission based on medication use. For additional questions, treatment providers can contact the Bureau of Program Licensure, and SCAs can contact the Treatment Division.